Clinical Trial Update: Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Sodium Stibogluconate, Paromomycin, and their combination for visceral leishmaniasis reports efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• Paromomycin (paromomycin)
• Sodium Stibogluconate/Paromomycin combination
• Sodium stibogluconate (sodium stibogluconate)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Visceral Leishmaniasis | Phase 3 | Status: COMPLETED